Law Offices of Howard G. Smith Commences Investigation on Behalf of Osiris Therapeutics, Inc. Investors

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Osiris Therapeutics, Inc. (“Osiris” or the “Company”) (NASDAQ: OSIR) concerning the Company’s and its officers’ possible violations of federal securities laws.

On November 16, 2015, Osiris filed its quarterly financial report with the SEC on Form 10-Q, which disclosed multiple unfavorable restatements of past financial reporting. On this news, Osiris shares fell $3.01, or 21.5% to close at $10.97 per share on November 17, 2015.

If you purchased Osiris securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151124006373/en/